Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Vaccine|December 23, 2008
Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenzaYoko Shoji, Hong Bi, Konstantin Musiychuk, et al.
Plos Pathogens|December 3, 2019
Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposureCrystal W Burke, Jeffery W Froude, Franco Rossi, et al.
Human Vaccines & Immunotherapeutics|January 9, 2013
A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challengeYoko Shoji, R Mark Jones, Vadim Mett, et al.
Stem Cells and Development|March 23, 2013
Plant-produced human recombinant erythropoietic growth factors support erythroid differentiation in vitroKonstantin Musiychuk, Rajarajeswari Sivalenka, Jennifer Jaje, et al.
Nature Communications|November 18, 2017
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25Stephen W Scally, Brandon McLeod, Alexandre Bosch, et al.
Clinical and Vaccine Immunology : CVI|July 1, 2011
A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparumChristine E Farrance, Amy Rhee, R Mark Jones, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
A plant-produced influenza subunit vaccine protects ferrets against virus challengeVadim Mett, Konstantin Musiychuk, Hong Bi, et al.
Plos One|November 22, 2013
A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized miceR Mark Jones, Jessica A Chichester, Vadim Mett, et al.
Human Vaccines|January 27, 2011
Antibodies to plant-produced Plasmodium falciparum sexual stage protein Pfs25 exhibit transmission blocking activityChristine E Farrance, Jessica A Chichester, Konstantin Musiychuk, et al.
Vaccine|February 14, 2022
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adultsKristopher M Paolino, Jason A Regules, James E Moon, et al.
Pageof 9